In this article, we demonstrated that maprotiline could restrain the growth of HCC cells through the ERK-SREBP2 signaling pathway, which suppresses cholesterol biosynthesis by interacting with CRABP1. The gene discussed is SREBF2; the disease is hepatocellular carcinoma.